Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Madrigal Pharmaceuticals Inc (MDGL)

122.2 0.27 (0.22%)

05-22 10:03

Open:

123.13

Pre. Close:

121.93

High:

124.14

Low:

121.2705

Volume:

13,871

Market Cap:

1741M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

133.926 - 134.61

134.61 - 135.135

Low:

118.737 - 119.397

119.397 - 119.903

Close:

120.881 - 121.993

121.993 - 122.844

Technical analysis  (as of: 2018-05-21 4:31:21 PM)

Overall:

      

Stoxline posted a STRONG SELL today, downgraded from higher rating. This stock seems to be very strong for short side. So you may continue to hold the short positions or sell your long positions. You are relatively safe to short or sell as long as the BUY warning is not issued.

Target:

Six months: 158.50     One year: 185.13

Support:

Support1: 116.08    Support2: 103.96

Resistance:

Resistance1: 135.70    Resistance2: 158.50

Pivot:

121.08

Moving Averages:

MA(5): 128.91     MA(20): 119.03

MA(100): 120.07     MA(250): 67.66

MACD:

MACD(12,26): 3.32     Signal(12,26,9): 2.15

%K %D:

%K(14,3): 70.89     %D(3): 81.91

RSI:

RSI(14): 51.52

52-Week:

High: 154.75  Low: 13.09  Change(%): 649.4

Average Vol(K):

3-Month: 26109  10-Days 18065

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
MDGL has closed below upper band by 47.0%. Bollinger Bands are 4.4% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-05-19T16:35:08-04:00
Lucky Seven: Exelixis Bounces Back, Global Blood Therapeutics Bleeds

2018-05-18T00:13:29-04:00
On The Move: Viking Therapeutics

2018-05-17T01:52:55-04:00
Institutional Top Ideas Series: Opaleye Management

2018-05-08T15:02:53-04:00
Lucky Seven: Omeros Moves, Array Biopharma May Be Next

2018-05-03T05:28:00-04:00
Lucky Seven: An Introduction To My Top Biotechnology Picks

2018-05-02T10:47:42-04:00
Cirius Therapeutics completes enrollment in mid-stage study of lead candidate in NASH

2018-04-30T14:28:42-04:00
Viking Therapeutics a possible 10-bagger - William Blair

2018-04-25T05:17:57-04:00
Institutional Top Ideas Series: Baker Brothers

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

14.25

Shares Float (M)

5.57

% Held by Insiders

61.00

% Held by Institutions

37.40

Shares Short (K)

1363

Shares Short Prior Month (K)

283

Stock Financials

EPS

-1.800

EPS Est. Current Year

-2.670

EPS Est. Next Year

-3.560

EPS Est. Next Quarter

-0.750

Forward EPS

-5.819

Book Value (p.s.)

9.690

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-28.2

Return on Equity (ttm)

-29.8

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-1.172

Qtrly Earnings Growth

Operating Cash Flow (M)

-27.19

Levered Free Cash Flow (M)

-16.63

atoplab.com

Valuation

P/E

-67.74

P/E Growth Ratio

-0.08

P/BV

12.58

P/S

P/CF

-63.91

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2016-07-25

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.